![]() Codex DNA Codex DNA (formerly SGI-DNA) is a biology company that provides solutions for DNA, RNA, and protein synthesis. | ![]() Senti Biosciences Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies. | ![]() Avrobio Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. | ||
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 2012 | Founding Date N/A |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations South San Francisco, US HQ | Locations Menlo Park, US HQ | Locations Cambridge, US HQ |
Employees | Employees 108 | Employees 916% decrease | Employees 871% decrease | Employees 8573% increase |
Valuation ($) | Valuation ($) 2.7 m | Valuation ($) 10.2 m | Valuation ($) N/A | Valuation ($) 5.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $27.5m (FY, 2023) | Revenue (est.) $22k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($47.7m) (FY, 2023) | Net income ($61.4m) (FY, 2025) | Net income N/A | Net income ($74.2m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 25m | Total funding raised $ 53m | Total funding raised N/A | Total funding raised $ 85m |

Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
View company
Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
View company